Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can your own fat help heal scars?

NCT ID NCT07763275

Symptom relief Sponsor: Benha University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This study tests whether a single injection of nanofat—made from a person's own fat—can improve the appearance of atrophic scars caused by burns or trauma. Each participant has two similar scars: one gets the nanofat injection plus silicone gel, and the other gets only silicone gel. Over three months, researchers compare changes in scar appearance and patient satisfaction between the two sites.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Autologous nanofat injection (a procedure using the participant's own fat tissue) followed by topical silicone gel
What this could lead to
If effective, this could offer a minimally invasive way to improve the appearance of atrophic scars using a person's own fat.
What could go wrong
This is a small, early-stage trial with only 20 participants, so results may not apply broadly. The procedure carries typical risks of fat harvesting and injection, such as swelling or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

20 people

The number who actually took part.

Started

Oct 2024

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 years or older. * Presence of clinically diagnosed atrophic postburn or posttraumatic scars. * Scars were stable and mature at the time of enrollment. * Presence of two comparable scar areas suitable for the split-scar study design. * Scar sites were suitable for standardized clinical and photographic assessment. * Participants were willing to undergo a single session of autologous nanofat injection. * Participants were able to comply with the study visits and 3-month follow-up. * Written informed consent was obtained before participation. Exclusion Criteria * Hypertrophic scars or keloids. * Active infection, inflammation, ulceration, or dermatitis at the selected scar sites. * Previous procedural treatment of the selected scar sites that could affect study assessment. * Significant uncontrolled systemic disease that could interfere with wound healing or treatment. * Bleeding disorders or other contraindications to the fat-harvesting or injection procedure. * Pregnancy or breastfeeding. * Known allergy or intolerance to the topical silicone gel used in the study. * Inability to provide informed consent or comply with study follow-up. * Any medical condition considered by the investigator to pose an unacceptable risk or interfere with study evaluation. Exclusion Criteria: \-

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Atrophic scar are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

platelet-type bleeding disorder 10 severe cutaneous adverse reaction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Atrophic scar Postburn scars; posttraumatic scars Scar

Contacts and locations

Locations

  • Benha faculty of medicine hospital

    Banhā, Qaluybia, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.